Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Kane FJ et al. Psychoendocrine study of oral contraceptive agents. 1970 Am J Psychiatry pmid:4394090
Vernet D [Gestagens: a new method of hormonal therapy in benign prostatic hypertrophy]. 1970 Urol. Int. pmid:4112432
Aghari K Influence of nor-ethisterone enanthate on the structure of ovary, particularly corpus luteum. 1970 J Obstet Gynaecol India pmid:12275253
Beyer G and Behrman SJ Myometrial activity and the IUCD. 3. Effect of contraceptive pills. 1970 Am. J. Obstet. Gynecol. pmid:5410390
Schardein JL et al. Long-term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. 1970 Toxicol. Appl. Pharmacol. pmid:5416742
Imai K and Hayashi Y Steroid-induced intrahepatic cholestasis in mice. 1970 Jpn. J. Pharmacol. pmid:5312929
Craft IL et al. Oral contraceptives and amino acid utilization. 1970 Am. J. Obstet. Gynecol. pmid:5479691
Bowman JA Experience with oral contraceptives in the immediate puerperium: effect on breast engorgement and menstrual flow. 1970 Fertil. Steril. pmid:5411034
McFarland HR Regression of cerebral lesions after cessation of oral contraceptives. 1970 South. Med. J. pmid:5411921
Szabo AJ et al. Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive. 1970 N. Engl. J. Med. pmid:5417729
Curwen S The treatment of advanced carcinoma of the breast with SH 420. 1970 Clin Radiol pmid:5420271
Franchimont P et al. Suppressive action of norethisterone enanthate and acetate on gonadotropin. (FSH and LH) levels. Radioimmunoassay in eugonadal and postmenopausal women. 1970 Obstet Gynecol pmid:5422095
Macela A [Norethisterone Spofa]. 1970 Cas. Lek. Cesk. pmid:5426297
Lotvin BR and Berman E Once-a-month oral contraceptive: quinestrol and quingestanol. 1970 Obstet Gynecol pmid:5446728
Singh OS and Carr DH A study of the effects of certain hormones on human cells in culture. 1970 Can Med Assoc J pmid:5447714
Larsson-Cohn U [Peroral contraception (7): metabolic changes]. 1970 Lakartidningen pmid:5478699
Nielsen JA [Jaundice following norethisterone plus mestranol (Plan)]. 1970 Ugeskr. Laeg. pmid:5487344
Mazaheri A et al. Metabolism of lynestrenol to norethisterone by liver homogenate. 1970 J. Endocrinol. pmid:5431695
Briggs MH and Briggs M Contraceptives and serum proteins. 1970 Br Med J pmid:5454345
Sabour MS and Fadel HE The carpal tunnel syndrome--a new complication ascribed to the "pill". 1970 Am. J. Obstet. Gynecol. pmid:5458584
McQuarrie HG et al. Cytogenetic studies on women using oral contraceptives and their progeny. 1970 Am. J. Obstet. Gynecol. pmid:4096928
Nagel R and Hargenda B [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate]. 1970 Hinyokika Kiyo pmid:4097356
Larsson-Cohn U [Peroral contraception (5): continuing low dosage treatment]. 1970 Lakartidningen pmid:4097873
Larsson-Cohn U et al. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens. 1970 Acta Endocrinol. pmid:5468622
Neumann F et al. Effects of oal contraceptives on the fetus. 1970 Lancet pmid:4098692
Elstein M Low-dose progestagens as contraceptive agents. 1970 IPPF Med Bull pmid:12255089
Miller GH and Hughes LR Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants. 1970 Obstet Gynecol pmid:5409834
Ferrari AN et al. [Use of norethindrone .35 mg in disorders of the menstrual cycle]. 1970 J Bras Ginecol pmid:12259292
Klinger G et al. [Efficacy of Non-ovlon in female patients with acne vulgaris]. 1970 Z Arztl Fortbild (Jena) pmid:4251329
Rauscher H [Comparative studies of the effect of various gestagens with special reference to the manifestation of rhythmic effects]. 1970 Bull Schweiz Akad Med Wiss pmid:4251826
Sissons C and Hall DR Intracranial venous thrombosis complicating oral contraception. 1970 Lancet pmid:4194719
Darragh A Indications for therapy with progestational agents. 1970 Bull Schweiz Akad Med Wiss pmid:5534331
Sabell AG Oral contraceptives and the contact lens wearer. 1970 Br J Physiol Opt pmid:5512797
Berman E The once-a-month pill. 1970 J Reprod Med pmid:5521943
Cowen PH Treatment of glaucoma with norethisterone. 1970 Trans Aust Coll Ophthalmol pmid:5525171
Aström G Synchronization of oestrus in heifers with norethisterone. 1970 Acta Vet. Scand. pmid:5528635
Heikel TA and Lathe GH The effect of 17-alpha-ethinyl-substituted steroids on adenosine triphosphatases of rat liver plasma membrane. 1970 Biochem. J. pmid:4248619
Haller J Central effects of endogenous progesterone and synthetic progestational agents. 1970 Bull Schweiz Akad Med Wiss pmid:5510171
Garcia CR Endocrine approach in the management of dysfunctional uterine bleeding. 1970 Clin Obstet Gynecol pmid:4322145
Maia H [Therapeutic effects of low doses of norethindrone in disorders of the menstrual cycle]. 1970 J Bras Ginecol pmid:12334528
Boveris A and Stoppani AO Inhibition of electron and energy transfer in mitochondria by 19-nor-ethynyltestosterone acetate. 1970 Arch. Biochem. Biophys. pmid:4322290
Takemura T and Uragami M [Changes of the menstrual cycle by ST-613 (Sophia-A)]. 1970 Horumon To Rinsho pmid:5465005
Spellacy WN et al. Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives. 1970 Am. J. Obstet. Gynecol. pmid:4188445
Iwata K [Experimental use of ST-613 (norethisterone 1.Omg plus mestranol 0.05mg]. 1970 Horumon To Rinsho pmid:5465537
Martínez-Manautou J et al. The ultrastructure of liver cells in women under steroid therapy. II. Contraceptive therapy. 1970 Acta Endocrinol. pmid:4097029
Horne CH et al. Effect of combined oestrogen-progestogen oral contraceptives on serum-levels of alpha 2-macroglobulin, transferrin, albumin, and IgG. 1970 Lancet pmid:4188620
Malkasian GD and Mayberry WE Serum total and free thyroxine and thyrotropin in normal and pregnant women, neonates, and women receiving progestogens. 1970 Am. J. Obstet. Gynecol. pmid:4098396
Ledger WJ Ortho 1557-O. A new oral contraceptive. 1970 Apr-Jun Int. J. Fertil. pmid:5430391
Eben-Moussi E and van den Driessche J [Evaluation of the biological activity of a new progestational hormone: quingestanol acetate]. 1970 Jan-Feb Therapie pmid:5436801
Neme B et al. [Effects of norethindrone on the premenstrual tension syndrome]. 1970 Jan-Mar Matern Infanc (Sao Paulo) pmid:5534601